19 June 2013
Keywords: rhone-poulenc, oncology, products, drive, growth, doubts, emerge
Article | 06 May 1999
Rhone-Poulenc has posted satisfactory results for the first quarter of1999, especially for its life sciences operations, though the firm
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 May 1999
5 May 1999
18 June 2013
© 2013 thepharmaletter.com